EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Design and Optimization of Trastuzumab-Functionalized Nanolipid Carriers for Targeted Capecitabine Delivery: Anti-Cancer Effectiveness Evaluation in MCF-7 and SKBR3 Cells

Shubhashree Das iD, Bhabani Sankar Satapathy iD, Gurudutta Pattnaik iD, Sovan Pattanaik iD, Yahya Alhamhoom iD, Mohamed Rahamathulla iD, Mohammed Muqtader Ahmed iD, Ismail Pasha iD

International Journal of Nanomedicine · 2025

DOI: 10.2147/ijn.s541332 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2025. Verfasst von Shubhashree Das und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, School of Pharmacy and Life Sciences, Centurion University of Technology and Management, Odisha, India. Hauptthemen laut MEDLINE: Capecitabine, Trastuzumab, Breast Neoplasms, Drug Carriers. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CapecitabineTrastuzumabBreast NeoplasmsDrug CarriersNanoparticlesHumansMCF-7 CellsFemaleDrug LiberationParticle SizeLiposomesAntineoplastic AgentsCell SurvivalCell Line, TumorDrug Delivery SystemsErb-b2 Receptor Tyrosine Kinases

Stichwörter der Autor:innen

MTT assaybreast cancercapecitabinenanolipid carriertrastuzumab

Substanzen

CapecitabineTrastuzumabDrug CarriersLiposomesAntineoplastic AgentsErb-b2 Receptor Tyrosine Kinases

Autor:innen und Institutionen

  • Department of Pharmaceutics, School of Pharmacy and Life Sciences, Centurion University of Technology and Management, Odisha, India.
  • Department of Pharmaceutics, GITAM School of Pharmacy, GITAM Deemed to Be University, Hyderabad Campus, Telangana, India.
  • Department of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Siksha O Anusandhan Deemed to be University, Bhubaneswar, Odisha, India.
  • Department of Pharmaceutics, College of Pharmacy, King Khalid University, Al Faraa, Abha, 62223, Saudi Arabia.
  • Department of Pharmaceutics, College of Pharmacy, Prince Sattam bin Abdul Aziz University, Al Kharj, 11942, Saudi Arabia.
  • Department of Pharmacology, Orotta College of Medicine and Health Science, Asmara, Eritrea.

ORCID-Profile: Shubhashree Das, Bhabani Sankar Satapathy, Gurudutta Pattnaik, Sovan Pattanaik, Yahya Alhamhoom, Mohamed Rahamathulla, Mohammed Muqtader Ahmed, Ismail Pasha

Zitieren

APA

Das, S., Satapathy, B. S., Pattnaik, G., Pattanaik, S., Alhamhoom, Y., Rahamathulla, M., Ahmed, M. M., & Pasha, I. (2025). Design and Optimization of Trastuzumab-Functionalized Nanolipid Carriers for Targeted Capecitabine Delivery: Anti-Cancer Effectiveness Evaluation in MCF-7 and SKBR3 Cells. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s541332

Vancouver

Das S, Satapathy BS, Pattnaik G, Pattanaik S, Alhamhoom Y, Rahamathulla M, et al. Design and Optimization of Trastuzumab-Functionalized Nanolipid Carriers for Targeted Capecitabine Delivery: Anti-Cancer Effectiveness Evaluation in MCF-7 and SKBR3 Cells. International Journal of Nanomedicine. 2025. doi:10.2147/ijn.s541332

BibTeX
@article{Das2025,
  author = {Das, Shubhashree and Satapathy, Bhabani Sankar and Pattnaik, Gurudutta and Pattanaik, Sovan and Alhamhoom, Yahya and Rahamathulla, Mohamed and Ahmed, Mohammed Muqtader and Pasha, Ismail},
  title = {Design and Optimization of Trastuzumab-Functionalized Nanolipid Carriers for Targeted Capecitabine Delivery: Anti-Cancer Effectiveness Evaluation in MCF-7 and SKBR3 Cells},
  journal = {International Journal of Nanomedicine},
  year = {2025},
  doi = {10.2147/ijn.s541332}
}
Kostenlos starten →